FINWIRES · TerminalLIVE
FINWIRES

Top Midday Decliners

By

Futu (FUTU), UP Fintech's (TIGR) Tiger Brokers unit, and Longbridge Securities face planned penalties from China's securities regulator for operating in mainland China without licenses, Bloomberg reported.

Shares of Futu sank 27% following an increase in intraday trading volume to over 54.4 million from a daily average of about 1.69 million.

Shares of UP Fintech slumped 23% as intraday trading volume advanced to more than 63.8 million from a daily average of about 2.57 million.

BJ's Wholesale Club (BJ) reported Friday fiscal Q1 adjusted earnings declined year over year, taking the shine off its revenue beat.

Shares were down 8%, with intraday trading volume at more than 4.06 million versus the stock's daily average of about 1.92 million.

Price: $90.76, Change: $-33.10, Percent Change: -26.72%

Related Articles

Wire

Advance Auto Parts Needs to Show Consistent Execution as Industry Tailwinds Recede, UBS Says

Advance Auto Parts' (AAP) fiscal Q1 results indicate that its turnaround is gaining traction, but the company needs to show its outperformance is due to consistent execution as industry tailwinds recede, UBS Securities said in a note Thursday.The company reported another quarter of comparable stores sales growth and an operating margin improvement of over 400 basis points, while taking steps to optimize profitability by reducing reliance on large professional accounts that don't provide a commensurate return on service investment, according to the note."For the stock to work in a meaningful way from here, the path will require consistent execution over the span of several quarters," analysts said, adding that the company needs to generate an extra 250 basis points of margin expansion to attain its long-term target even if it achieves the high end of its full-year operating margin guidance.UBS maintained its neutral rating and adjusted the price target to $65 from $60.Shares of Advance Auto Parts were down 1% in Friday trading.Price: $58.03, Change: $-0.59, Percent Change: -1.01%

$AAP
Wire

Market Chatter: Uber Technologies Weighing Full Buyout of Delivery Hero

Uber Technologies (UBER) is evaluating options for a complete buyout of Delivery Hero, Bloomberg reported Friday, citing sources familiar with the matter.The ride-sharing firm is partnering with financial consultants to explore expanding its ownership after recently increasing its position in the Frankfurt-traded entity, while also contacting other stakeholders regarding potential interest, the media outlet reported.Delivery Hero said Monday Uber has acquired additional shares and instruments, and now owns 19.5% of the issued capital, with a further 5.6% in options. Morgan Stanley (MS) has helped Uber to build its stake using derivatives, according to the report.Uber mentioned this week that it does not intend to increase its ownership to 30% or higher at this time, but reviews its portfolios routinely for favorable opportunities, Bloomberg reported.Uber, Delivery Hero, and Morgan Stanley did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $72.63, Change: $-0.98, Percent Change: -1.33%

$MS$UBER
Wire

Top Midday Gainers

Dell Technologies' (DELL) shares soared 16.6% after Wells Fargo raised its price target to $270 from $180.More than 10.6 million shares of the company traded intraday compared with a daily average of about 8 million.CIBC Capital Markets raised its price target on BlackBerry (BB) to $8.50 from $6, with Analyst Todd Coupland maintaining an outperformer rating on the shares."...Management signalled better operating visibility and a clearer path to profitable growth across both QNX and Secure Communications," Coupland said in a note to clients.Shares of BlackBerry jumped 18% amid a surge in intraday trading volume to over 34.6 million from a daily average of roughly 15.9 million.Akari Therapeutics (AKTX) reported positive preclinical data highlighting synergistic cytotoxic activity of AKTX-101 in combination with KRAS inhibition in KRAS-mutated pancreatic cancer models.Shares more than doubled as intraday trading volume catapulted to over 17.2 million from a daily average of about 68,000.Price: $294.87, Change: $+42.07, Percent Change: +16.64%

$AKTX$BB$DELL